Journal of Case Reports and Reviews in Medicine (ISSN: 3069-0749)

The Challenges of Anesthetic Management in Patients with Heart Failure Undergoing Resection of a Giant Catecholamine-Secreting Pheochromocytoma: A Case Report

Arthur Resende Fernandes, Guilherme Lara Silveira Freitas MD, Lucas Nunes Bandeira de Melo MD, Marin Ayres Delgado MD

Received : January 29, 2025 | Published : March 14, 2025

Citation: Fernandes AR, Freitas GLS, de Melo LNB, Delgado MA. The Challenges of Anesthetic Management in Patients with Heart Failure Undergoing Resection of a Giant Catecholamine-Secreting Pheochromocytoma: A Case Report. J Case Rep Rev Med. 2025;1(1);1-3. DOI: 10.64978/jcrrm-0110

Abstract

The anesthetic management of patients with heart failure undergoing resection of giant catecholamine-secreting pheochromocytomas presents significant challenges due to the complex hemodynamic changes induced by excessive catecholamine release. This case report details the perioperative management of a 35-year-old female with cardiogenic shock, acute pulmonary edema, and left ventricular dysfunction secondary to a giant pheochromocytoma. Advanced preoperative preparation with adrenergic blockers and intraoperative monitoring, including pulmonary artery catheterization, were employed to optimize hemodynamic stability. During surgery, hypertensive episodes triggered by tumor manipulation required nitroprusside infusion, while vasopressors and inotropes were carefully titrated to address hypotension and maintain ventricular-arterial coupling. The six-hour procedure, involving tumor resection and distal pancreatectomy, was complicated by significant hemodynamic fluctuations but ultimately successful. This report highlights the critical role of multidisciplinary planning and advanced hemodynamic monitoring in managing perioperative risks associated with pheochromocytoma resection. Strategies such as goal-directed fluid therapy, volume resuscitation, and targeted pharmacologic interventions are essential in addressing the unique challenges posed by these tumors, particularly in patients with preexisting cardiac dysfunction.